S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
The single greatest medical breakthrough of all time? (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
The single greatest medical breakthrough of all time? (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
The single greatest medical breakthrough of all time? (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
The single greatest medical breakthrough of all time? (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
The single greatest medical breakthrough of all time? (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
The single greatest medical breakthrough of all time? (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
The single greatest medical breakthrough of all time? (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
The single greatest medical breakthrough of all time? (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
NYSE:CVII

Churchill Capital Corp VII (CVII) Stock Forecast, Price & News

$10.45
+0.01 (+0.10%)
(As of 09/20/2023 ET)
Compare
Today's Range
$10.42
▼
$10.46
50-Day Range
$10.35
▼
$10.80
52-Week Range
$9.79
▼
$10.80
Volume
7.47 million shs
Average Volume
617,437 shs
Market Capitalization
$966.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

CVII stock logo

About Churchill Capital Corp VII (NYSE:CVII) Stock

Churchill Capital Corp VII, a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

CVII Price History

CVII Stock News Headlines

September 10, 2023 | markets.businessinsider.com
Churchill Capital A is about to announce its earnings — here's what to expect
August 1, 2023 | finance.yahoo.com
Cheshire investment group heads for $1.6bn NY listing with Michael Klein
September 21, 2023 | Chaikin Analytics (Ad)
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
May 5, 2023 | marketwatch.com
8-K: Churchill Capital Corp VII
February 23, 2023 | seekingalpha.com
Sibling SPACs Churchill VI, VII sign merger LOIs with unnamed companies
September 13, 2022 | nasdaq.com
Churchill Capital Corp VII - Class A Shares Near 52-Week High - Market Mover
February 15, 2022 | finance.yahoo.com
Is Churchill Capital Corp VII's (NYSE:CVII) Shareholder Ownership Skewed Towards Insiders?
January 27, 2022 | nasdaq.com
Churchill Capital Corp VII - Class A Shares Close in on 52-Week Low - Market Mover
September 21, 2023 | Chaikin Analytics (Ad)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
January 13, 2022 | nasdaq.com
Churchill Capital Corp VII Class A Common Stock (CVII)
August 29, 2021 | nasdaq.com
Churchill Capital Corp VII - Class A Shares Near 52-Week Low - Market Mover
August 22, 2021 | wsj.com
Churchill Capital Corp. VII
August 19, 2021 | nasdaq.com
Could The Churchill Capital Corp VII (NYSE:CVII) Ownership Structure Tell Us Something Useful?
August 19, 2021 | finance.yahoo.com
What You Need To Know About Churchill Capital Corp VII's (NYSE:CVII) Investor Composition
August 14, 2021 | nasdaq.com
Churchill Capital Corp VII - Class A Shares Approach 52-Week Low - Market Mover
June 25, 2021 | finance.yahoo.com
Churchill Capital Corp VII (CVII-WT) stock forecast and price target
June 19, 2021 | barrons.com
Churchill Capital Corp. VII Cl A
See More Headlines
Receive CVII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Churchill Capital Corp VII and its competitors with MarketBeat's FREE daily newsletter.

CVII Company Calendar

Today
9/21/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Holding & other investment offices
Sub-Industry
N/A
Sector
Unclassified
Current Symbol
NYSE:CVII
CUSIP
N/A
CIK
1828248
Web
vii.churchillcapitalcorp.com
Phone
212-380-7500
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$71.05 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-77.66%
Return on Assets
3.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.32
Quick Ratio
0.32

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.41 per share
Price / Cash Flow
25.30
Book Value
($0.27) per share
Price / Book
-38.70

Miscellaneous

Outstanding Shares
92,520,000
Free Float
74,013,000
Market Cap
$966.83 million
Optionable
Not Optionable
Beta
0.05
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Michael S. Klein (Age 59)
    Pres, Chairman of Directors & CEO
  • Mr. Lee Jay Taragin (Age 57)
    Chief Financial Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













CVII Stock - Frequently Asked Questions

How have CVII shares performed in 2023?

Churchill Capital Corp VII's stock was trading at $9.97 at the beginning of 2023. Since then, CVII shares have increased by 4.8% and is now trading at $10.45.
View the best growth stocks for 2023 here.

Are investors shorting Churchill Capital Corp VII?

Churchill Capital Corp VII saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 10,100 shares, an increase of 16.1% from the August 15th total of 8,700 shares. Based on an average daily volume of 317,900 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company's stock are sold short.
View Churchill Capital Corp VII's Short Interest.

What ETFs hold Churchill Capital Corp VII's stock?

ETFs with the largest weight of Churchill Capital Corp VII (NYSE:CVII) stock in their portfolio include SPAC and New Issue ETF (SPCX).CrossingBridge Pre-Merger SPAC ETF (SPC).

What is Churchill Capital Corp VII's stock symbol?

Churchill Capital Corp VII trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVII."

Who are Churchill Capital Corp VII's major shareholders?

Churchill Capital Corp VII's stock is owned by a number of institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.93%), Castle Creek Arbitrage LLC (0.88%), Picton Mahoney Asset Management (0.67%), P Schoenfeld Asset Management LP (0.57%), Hsbc Holdings PLC (0.33%) and Mint Tower Capital Management B.V. (0.29%).

How do I buy shares of Churchill Capital Corp VII?

Shares of CVII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Churchill Capital Corp VII's stock price today?

One share of CVII stock can currently be purchased for approximately $10.45.

How much money does Churchill Capital Corp VII make?

Churchill Capital Corp VII (NYSE:CVII) has a market capitalization of $966.83 million.

How can I contact Churchill Capital Corp VII?

Churchill Capital Corp VII's mailing address is 640 FIFTH AVENUE 12TH FLOOR, NEW YORK NY, 10019. The official website for the company is vii.churchillcapitalcorp.com. The company can be reached via phone at 212-380-7500.

This page (NYSE:CVII) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -